Monday, February 24, 2025 | 05:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 8 - Sun Pharma

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
Updated On : 10 May 2021 | 12:24 PM IST

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs

Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
Updated On : 12 Apr 2021 | 11:02 AM IST

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief
Updated On : 11 Apr 2021 | 11:48 AM IST

US FDA nod to Teva for key specialty product to weigh on Sun Pharma

Strong US portfolio, margin gains and India business growth to support stock

US FDA nod to Teva for key specialty product to weigh on Sun Pharma
Updated On : 06 Apr 2021 | 1:33 AM IST

Stock picks by Sameet Chavan: Buy Happiest Minds, Prakash Industries

The recent price chart displays a 'Bullish Flag' breakout in Happiest Minds' stock

Stock picks by Sameet Chavan: Buy Happiest Minds, Prakash Industries
Updated On : 05 Apr 2021 | 8:39 AM IST

Stock markets start new fiscal on a high, Sensex reclaims 50,000-level

IndusInd Bank, Kotak Mahindra Bank, ICICI Bank, Sun Pharma, Bajaj Finance, and UltraTech Cement were prominent gainers

Stock markets start new fiscal on a high, Sensex reclaims 50,000-level
Updated On : 02 Apr 2021 | 12:43 AM IST

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market

Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market, the world's largest market for pharmaceutical products, for various reasons

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market
Updated On : 14 Mar 2021 | 11:30 AM IST

JB Chemicals: New launches, market share gains to drive growth

Key chronic segments have helped the JB Chemicals outperform the Indian pharma market.

JB Chemicals: New launches, market share gains to drive growth
Updated On : 11 Mar 2021 | 1:04 AM IST

Sun Pharma to launch complete range of generic anti-epilepsy drug

The firm said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price

Sun Pharma to launch complete range of generic anti-epilepsy drug
Updated On : 23 Feb 2021 | 3:59 PM IST

Stocks to watch: ITC, Sun Pharma, Grasim, Power Grid, ACC, aviation stocks

Markets regulator Sebi on Thursday allowed Thomas Cook (India) to withdraw its buyback offer because of substantial deterioration in the company's financial position

Stocks to watch: ITC, Sun Pharma, Grasim, Power Grid, ACC, aviation stocks
Updated On : 12 Feb 2021 | 8:41 AM IST

Here's a Bull Spread strategy on Sun Pharma by Nandish Shah of HDFC Sec

The stock price has witnessed running correction of 10 per cent from the recent high

Here's a Bull Spread strategy on Sun Pharma by Nandish Shah of HDFC Sec
Updated On : 12 Feb 2021 | 8:19 AM IST

Sun Pharma, 7 executives settle dispute with Sebi; pay Rs 2.92 cr

Two whistle blowers had alleged that Sun Pharma and its subsidiary Sun Pharmaceutical Laboratories diverted funds through its sole distributor in India Aditya Medisales

Sun Pharma, 7 executives settle dispute with Sebi; pay Rs 2.92 cr
Updated On : 12 Feb 2021 | 3:00 AM IST

Domestic drug market growth slows top 4.5% in January, some therapies drag

Respiratory segment and anti-infectives contract; Cardiac, anti-diabetic growth rates plummet

Domestic drug market growth slows top 4.5% in January, some therapies drag
Updated On : 05 Feb 2021 | 11:28 PM IST

Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs

At 12:57 pm, Nifty Pharma index, the top gainer among sectoral indices, was up 4.2 per cent, as compared to 1.3 per cent gain in the benchmark Nifty50 index

Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs
Updated On : 03 Feb 2021 | 1:32 PM IST

Sun Pharma Q3 PAT doubles to Rs 1,852 cr, rides on record quarterly revenue

The company has repaid debt of about $490 million in 9MFY21; filings for 90 ANDAs await US FDA approval

Sun Pharma Q3 PAT doubles to Rs 1,852 cr, rides on record quarterly revenue
Updated On : 30 Jan 2021 | 1:12 AM IST

Sun Pharma gains 6% on good Q3 results, Rs 5.50 per share interim dividend

Analysts had expected the revenues to grow around 6 per cent YoY and Ebitda margins expected to improve 42 bps YoY to 23 per cent

Sun Pharma gains 6% on good Q3 results, Rs 5.50 per share interim dividend
Updated On : 29 Jan 2021 | 3:26 PM IST

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
Updated On : 11 Jan 2021 | 6:10 AM IST

Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility

The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results

Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility
Updated On : 08 Jan 2021 | 10:33 AM IST

BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%

Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the intra-day trade today. It has surged 11 per cent in the past four trading days on the BSE

BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%
Updated On : 04 Dec 2020 | 2:47 PM IST

Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes

In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Friday

Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes
Updated On : 01 Dec 2020 | 12:26 PM IST